Advancing Treatment of Rheumatoid Arthritis Video - Brigham and Women’s Hospital

Rheumatoid arthritis is the most common type of chronic arthritis caused by the immune system - affecting 1.3 million Americans. Symptoms and their degree of impact can vary greatly, and the earlier the disease is diagnosed and treatment begins the better. Fortunately, there have been exciting advancements in rheumatoid arthritis treatment, slowing down the progression of joint damage.
Michael E. Weinblatt, MD, Co-Director, Clinical Rheumatology and R. Bruce and Joan M. Hickey Distinguished Chair in Rheumatology, Division of Rheumatology, Immunology and Allergy at Brigham and Women’s Hospital (BWH), discusses rheumatoid arthritis treatment along with an overview of promising research at BWH.
The BWH Division of Rheumatology, Immunology and Allergy’s has the largest research funding base and investigative team of any rheumatology and allergy program in the country. It has helped to make significant advances in the treatment of arthritis and other joint diseases, including the recent development of a highly effective medication for rheumatoid arthritis..
Learn more: